Jenny Marlowe

Jenny Marlowe

Chief Tech/Sci/R&D Officer at SOLID BIOSCIENCES INC.

Net worth: 59 763 $ as of 29/04/2024

47 year
Health Technology
Consumer Services
Technology Services

Profile

Jenny Marlowe is currently the Chief Scientific Officer at The Friedreich's Ataxia Research Alliance and Solid Biosciences, Inc. She previously worked as the Director-Translational Safety Models at Novartis Institutes of Biomedical Research in 2017, Vice President at bluebird bio, Inc. from 2020 to 2021, and Chief Scientific Officer at Aavantibio, Inc. from 2021 to 2022.
Dr. Marlowe completed her undergraduate degree at Miami University and obtained her doctorate from the University of Cincinnati (Ohio).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/02/2024 6,998 ( 0.02% ) 59 763 $ 29/04/2024

Jenny Marlowe active positions

CompaniesPositionStart
SOLID BIOSCIENCES INC. Chief Tech/Sci/R&D Officer 31/12/2022
Chief Tech/Sci/R&D Officer 30/11/2022
All active positions of Jenny Marlowe

Former positions of Jenny Marlowe

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 30/11/2022
BLUEBIRD BIO, INC. Corporate Officer/Principal 19/11/2021
Corporate Officer/Principal 31/07/2017
See the detail of Jenny Marlowe's experience

Training of Jenny Marlowe

Miami University Undergraduate Degree
University of Cincinnati (Ohio) Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jenny Marlowe's experience

Connections

51

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BLUEBIRD BIO, INC.

Health Technology

SOLID BIOSCIENCES INC.

Health Technology

Private companies3

Technology Services

Health Technology

Health Technology

See company connections